Legislation expands treatment options, removes ban on Medicaid reimbursement at certain facilities
THURSDAY, Oct. 25, 2018 (HealthDay News) — A bipartisan bill meant to combat the United States’ opioid abuse epidemic was signed into law Oct. 24 by President Donald Trump.
The legislation, which also covers other types of substance abuse, expands treatment options and removes a ban on Medicaid reimbursing residential treatment at certain facilities with more than 16 beds, the Associated Press reported. There is also $60 million earmarked for infants who are born drug-dependent and authorization for programs that place drug offenders into treatment instead of in prison.
The legislation also requires the U.S. Postal Service to screen international packages for fentanyl, the AP reported.
Last year, nearly 48,000 people in the United States died of opioid overdoses.
Breathing Interventions May Curb Cravings With Substance Use
Adding Cognitive Behavioral Therapy, Self-Management Does Not Improve Opioid Taper Success
Many Adolescents Not Aware of Dangers of Fentanyl Use
About 30 Percent of Pediatric Surgery Patients Receive Opioid Rx
Full, Limited Functional Endoscopic Sinus Surgery Beneficial in Rhinosinusitis With Nasal Polyps
Randomized Trial of Early Vitrectomy Feasible for Postoperative Endophthalmitis
Botox Helpful in Alleviating Chronic Migraine in Pediatric Patients
Platelet-Rich Plasma, Shockwave Therapy Show Therapeutic Efficacy in Interstitial Cystitis